The public’s attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan

Abuhammad, Sawsan; Khabour, Omar F.; Alzoubi, Karem H.; Hamaideh, Shaher H.; Alzoubi, Baker A.; Telfah, Waed S.; El-zubi, Farah K.

doi:10.1371/journal.pone.0271625

Cited by 13 publications

(21 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding is also consistent with evidence linking increased intentions to receive seasonal influenza vaccination with older age groups. Inconsistent results were shown in previous studies from European countries concerning the effects of sociodemographic characteristics and intentions to get COVID-19 vaccination [35][36][37].…”

Section: Discussioncontrasting

confidence: 60%

Intentions to receive COVID-19 vaccination among people in Gaza Strip

Abusalem

Abuhammad²,

Sha³

et al. 2022

ELECTRON J GEN MED

Self Cite

View full text Add to dashboard Cite

This project assessed intentions to receive COVID-19 vaccine and its potential influencing factors among adults living in the Gaza Strip.Method: Data were collected from February through July 2021 when the vaccine distribution just started. An online cross-sectional survey was conducted using social media outlets. The respondents include a convenience sample of 325 individuals who are 18 years and older in the Gaza Strip. Bivariate statistics and logistic regressions were used to investigate the factors related to intention to receive vaccine.Results: Bivariate statistics found that the intention to get the vaccine is significantly higher for males (as compared to females), less educated, and married. Those with chronic disease are more likely to receive COVID-19-vaccine. However, when the other variables were controlled, only gender, profession, and perceived barriers significantly predicted the intentions to receive COVID-19 vaccine. Conclusion:This project highlighted variables that are associated with intentions to receive COVID-19 vaccine. These finding may be used to develop interventions to foster the acceptance of the vaccine among the people of Gaza Strip.

show abstract

Section: Discussioncontrasting

confidence: 60%

Intentions to receive COVID-19 vaccination among people in Gaza Strip

Abusalem

Abuhammad²,

Sha³

et al. 2022

ELECTRON J GEN MED

Self Cite

View full text Add to dashboard Cite

show abstract

“…Based on a study conducted in Spain, the concern of transmitting COVID-19 to the family (49.52%) and concern of self-infection (39.45%) were the most common reasons for vaccination, followed by socializing (31.0%) and travel (30.56%) [52]. Another study in Jordan also highlighted the similar findings regarding the acceptance of an annual dose of the COVID-19 vaccine, such as the potential of the additional dose in lowering the risk of contracting COVID-19 disease (62.2%), protecting family members from the virus and consequences, protecting their job (34.2%) and reducing the cost of hospital care (28.6%) [53]. These findings were similar to what we found-that self-protection, protecting family members, co-workers and the surrounding community motivate the respondents to receive the booster dose.…”

Section: Discussionmentioning

confidence: 64%

Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia

et al. 2022

View full text Add to dashboard Cite

Obtaining a booster dose of coronavirus disease 2019 (COVID-19) vaccine is required to maintain the protective level of neutralizing antibodies and therefore herd immunity in the community, and the success of booster dose programs depends on public acceptance. The aim of this study was to determine the acceptance of a booster dose of COVID-19 vaccine and its drivers and barriers in Indonesia. A cross-sectional survey was conducted in the provinces of Indonesia between 1 and 15 August 2022. Individuals who completed the primary series of the COVID-19 vaccine were asked about their acceptance of a booster dose. Those who refused the booster dose were questioned about their reasons. A logistic regression was used to determine the determinants associated with rejection of a booster dose of COVID-19 vaccine. A total of 2935 respondents were included in the final analysis. With no information on the efficacy and safety of the COVID-19 vaccine, 95% of respondents agreed to receive a booster dose if it were provided for free by the government. This acceptance was reduced to only 50.3% if the vaccine had a 75% efficacy with a 20% chance of side effects. The adjusted logistic regression analysis indicated that there were eight factors associated with the rejection of the booster dose: age, marital status, religion, occupation, type of the first two vaccines received, knowledge regarding the importance of the booster dose, belief that natural immunity is sufficient to prevent COVID-19 and disbelief in the effectiveness of the booster dose. In conclusion, the hesitancy toward booster doses in Indonesia is influenced by some intrinsic factors such as lack of knowledge on the benefits of the booster dose, worries regarding the unexpected side effects and concerns about the halal status of the provided vaccines and extrinsic determinants such as the effectiveness and safety of the vaccine. These findings suggest the need for more campaigns and promotions regarding the booster dose benefits to increase its acceptance.

show abstract

“…This is now a reality, and most Americans understand that COVID-19 is here to stay [ 1 ]. As mutations and natural selection continue to occur, new variants emerge and vaccines need to be continuously redeveloped [ 14 ] and adopted by the population [ 17 , 18 , 19 , 20 , 21 , 22 ]. In the U.S., the federal government has purchased 66 million doses of bivalent boosters that target BA.4 and BA.5 Omicron subvariants [ 108 ].…”

Section: Discussionmentioning

confidence: 99%

“…On the other hand, we likely need annual vaccine composition updates [ 18 ]. Surveys in Jordan show that less than 1 in 5 persons would take an annual booster [ 19 ], while about 2 in 3 Canadians [ 20 ] and more than 4 in 5 German-speaking adults would be willing [ 21 ]. Results in the U.S. are mixed, as surveys were conducted across sub-populations with different profiles [ 22 ].…”

Section: Introductionmentioning

confidence: 99%

A Scoping Review of Three Dimensions for Long-Term COVID-19 Vaccination Models: Hybrid Immunity, Individual Drivers of Vaccinal Choice, and Human Errors

2022

View full text Add to dashboard Cite

The virus that causes COVID-19 changes over time, occasionally leading to Variants of Interest (VOIs) and Variants of Concern (VOCs) that can behave differently with respect to detection kits, treatments, or vaccines. For instance, two vaccination doses were 61% effective against the BA.1 predominant variant, but only 24% effective when BA.2 became predominant. While doses still confer protection against severe disease outcomes, the BA.5 variant demonstrates the possibility that individuals who have received a few doses built for previous variants can still be infected with newer variants. As previous vaccines become less effective, new ones will be released to target specific variants and the whole process of vaccinating the population will restart. While previous models have detailed logistical aspects and disease progression, there are three additional key elements to model COVID-19 vaccination coverage in the long term. First, the willingness of the population to participate in regular vaccination campaigns is essential for long-term effective COVID-19 vaccination coverage. Previous research has shown that several categories of variables drive vaccination status: sociodemographic, health-related, psychological, and information-related constructs. However, the inclusion of these categories in future models raises questions about the identification of specific factors (e.g., which sociodemographic aspects?) and their operationalization (e.g., how to initialize agents with a plausible combination of factors?). While previous models separately accounted for natural- and vaccine-induced immunity, the reality is that a significant fraction of individuals will be both vaccinated and infected over the coming years. Modeling the decay in immunity with respect to new VOCs will thus need to account for hybrid immunity. Finally, models rarely assume that individuals make mistakes, even though this over-reliance on perfectly rational individuals can miss essential dynamics. Using the U.S. as a guiding example, our scoping review summarizes these aspects (vaccinal choice, immunity, and errors) through ten recommendations to support the modeling community in developing long-term COVID-19 vaccination models.

show abstract

The public’s attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan

Cited by 13 publications

References 62 publications

Intentions to receive COVID-19 vaccination among people in Gaza Strip

Intentions to receive COVID-19 vaccination among people in Gaza Strip

Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia

A Scoping Review of Three Dimensions for Long-Term COVID-19 Vaccination Models: Hybrid Immunity, Individual Drivers of Vaccinal Choice, and Human Errors

Contact Info

Product

Resources

About